ロード中...
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
The inverse relationship of plasma bilirubin levels with liver fat accumulation has prompted the possibility of bilirubin as a therapeutic for non-alcoholic fatty liver disease. Here, we used diet-induced obese mice with non-alcoholic fatty liver disease treated with pegylated bilirubin (bilirubin n...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7775678/ https://ncbi.nlm.nih.gov/pubmed/33390979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.594574 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|